Bio/Data Corporation is now offering a Tele-Check✓™ Calibration Verification Service for its platelet aggregometers. This calibration verification is performed over the phone while the aggregometer remains in the laboratory and is available for the PAP-8E and PAP-4 Series aggregometers in good working order. This service reduces downtime, save costs, and assures the platelet aggregometer is performing to published specifications. A service technician guides the user through the calibration verification process. Required materials are shipped to the laboratory in advance of the scheduled Tele-Check appointment. Calibration results generated by the instrument are submitted by the laboratory to the company for review by a Quality Control representative. Upon approval, a Certificate of Calibration will be issued along with a Calibration Sticker.
Read more

Introducing the new Thermo Scientific small benchtop centrifuges to fit both your space and applications, and designed for solid reliability and consistent results to stand out in your lab.
Fits in.

●  To your space, with its compact footprint.

●  To your applications, accommodating multi-laboratory settings with the flexibility to adapt with evolving clinical and research needs.

Stands-out with the following innovative Thermo Scientific™ technologies:

●  Secure push-button application versatility and cleaning convenience with Auto-Lock™ rotor exchange

●  One-handed, sample protection with ClickSeal™ biocontainment rotor lids, certified by the Public Health Laboratory Service, Microbiology Services, Porton Down, UK.

●  Maximized capacity from 24 x 5/7 mL blood tubes to microplates and microtubes, all in one versatile unit.
Read more

Energy efficiency is a vital feature of modern laboratory equipment, reducing both environmental impact and running costs. The innovative technology in Panasonic Eco VIP Ultra-low freezers reduces energy consumption by up to 55% compared with previous models, meaning possible savings of up to €5,000 in energy costs over 10 years. With less heat generation, users can also make savings on air conditioning. The Eco VIP Ultra-low freezers dramatically reduce carbon footprints and use natural refrigerants with low global warming potential. With Class IIa medical device certification, they provide secure storage for valuable research and irreplaceable clinical samples.
Read more

Two new ELISAs provide highly sensitive and specific screening for Borrelia antibodies in the serological diagnosis of Lyme disease. The Anti-Borrelia Select ELISA (IgG) and the Anti-Borrelia Select ELISA (IgM) are based on unique combinations of highly specific recombinant antigens from different Borrelia species. The IgG ELISA includes VlsE, which is the most important target antigen for the detection of Borrelia-specific IgG antibodies. All antigens contained in the assay substrate have been carefully selected for their diagnostic value and mixed in optimized concentrations to ensure maximum test sensitivity and specificity. Moreover, many of the antigens have been modified by molecular manipulation to boost their diagnostic performance.
The most important component of the IgM ELISA is covalently bound, recombinant dimeric OspC (OspC advanced), which is exclusive to this ELISA. OspC advanced represents the biologically active form of the antigen and provides over 30% higher specificity than traditionally used monomeric forms, while maintaining a high sensitivity. Since antibodies against OspC are produced by 90% of infected persons, inclusion of this optimized antigen significantly enhances the performance of the test in early-stage borreliosis screening.
The ELISAs yield significantly fewer cross reactions than lysate-based tests, for example in patients with autoimmune diseases or other infections such as Treponema pallidum. The inclusion of antigens from different human pathogenic Borrelia species ensures reliable results regardless of the infecting species.
The Anti-Borrelia Select ELISAs are part of a complete package from EUROIMMUN for borreliosis diagnostics, which also includes immunoblots for the confirmatory diagnostic step, indirect immunofluorescence tests, CSF tests, avidity tests and comprehensive automation concepts for all products.

Read more

Extending the company’s range of diagnostic testing solutions, the kits enable DNA extraction and the identification of polymorphisms in genes linked to disease or drug metabolism. The kits are real time PCR-based, and validated on multiple PCR instruments from leading manufacturers. These include thrombosis kits for the detection of polymorphisms in F5 and F2 genes, supporting disease management. The drug sensitivity kits determine an individual’s susceptibility to indirect anticoagulants and other drugs, including polymorphisms in CYP2C9, VKORC1, CYP2C19 genes. This knowledge is important in correct dosage prescription, which can vary hugely across genotypes. The Multi DNA extraction kit provides fast, easy extraction from various sample types, including serum, plasma, dry blood spots, urine, saliva and epithelial cells.
Read more